HIV assays : operational characteristics (Phase 1). Report 15, Antigen/antibody ELISAs
World Health Organization. (2004). HIV assays : operational characteristics (Phase 1). Report 15, Antigen/antibody ELISAs. Geneva : World Health Organization. http://www.who.int/iris/handle/10665/43059
MetadataShow full item record
Showing items related by title and MeSH subject.
Serial tumour markers serum carcinoembryonic antigen and cancer antigen 15-3 assays in detecting symptomatic metastasis in breast cancer patients Bahrami, A.; Mortazavizadeh, M.R.; Yazdi, M.F.; Chamani, M. (2012)The value of serum tumour markers in the prognosis of patients with breast cancer is controversial. This prospective study in Yazd, Islamic Republic of Iran, assessed the value of the tumour markers carcinoembryonic antigen [CEA] and cancer antigen [CA] 15-3 in 159 patients with primary breast cancer. CEA and CA15-3 assays [mean 14 per patient] were performed at diagnosis, end of surgery and chemotherapy and every 3 months in the first 2 years and every 6 months in second 2 years of the follow-up period. During follow-up, 33 patients [20.8%] ...